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Abstract
Choline is a dietary component and precursor of acetylcholine, a crucial neurotransmitter
for memory-related brain functions. In two double-blind, placebo-controlled cross-over
experiments, we investigated whether the food supplement choline bitartrate improved
declarative memory and working memory in healthy, young students one to two hours after
supplementation. In experiment 1, 28 participants performed a visuospatial working mem-
ory task. In experiment 2, 26 participants performed a declarative picture memorization
task. In experiment 3, 40 participants performed a verbal working memory task in addition to
the visuospatial working memory and declarative picture task. All tasks were conducted
approximately 60 minutes after the ingestion of 2.0–2.5g of either choline bitartrate or pla-
cebo. We found that choline did not significantly enhance memory performance during any
of the tasks. The null hypothesis that choline does not improve memory performance as
compared to placebo was strongly supported by Bayesian statistics. These results are in
contrast with animal studies suggesting that choline supplementation boosts memory per-
formance and learning. We conclude that choline likely has no acute effects on cholinergic
memory functions in healthy human participants.
Introduction
Consuming sufficient nutrients is at the base of healthy physical functioning and mental well-
being. The daily intake of dietary components is essential for the synthesis of the brain’s neuro-
transmitters and a lack of such chemical compounds can have serious consequences for health
and behavior [1, 2]. One such dietary components is choline, which is believed to be important
for healthy brain functioning and behavior.
Animal studies have shown that choline is a precursor of the major neurotransmitter acetyl-
choline [2–7], a neurotransmitter crucial for cholinergic memory functioning [8–16]. Choline
is chemically very similar to acetylcholine [17] and the synthesis of acetylcholine largely
depends on dietary choline intake [18–21]. Thus, choline is important for the synthesis of
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acetylcholine in animals [5]. As a result, the long-term effects of dietary choline availability on
the rodent’s brain and memory have been investigated extensively. For example, the brain’s
acetylcholine concentrations increase after an enriched choline diet [22] and memorization of
food locations improve after rats were administered with choline either prenatally [23–27],
around birth [26, 28], or later in life [29, 30] (for a review, see [31]). Furthermore, in cognitively
impaired mice prenatal choline supplementation also enhances performance in typical atten-
tion and memory-related tasks [23–25]. Yet other studies have demonstrated a link between a
choline deficient diet and impaired acetylcholine synthesis [32], and impaired memory in adult
animals [4, 33, 34]. In sum, the studies above suggest that there is a strong link between dietary
choline intake and memory functions in animals.
Due to the promising findings in animal studies, scientists have postulated that abnormali-
ties in choline availability and acetylcholine synthesis may give way to the development of
memory disorders such as Alzheimer and Parkinson dementia in humans [35–37]. Several
studies have tried to improve memory functioning in aged human patients suffering from
impaired memory by increasing the amount of choline in the diet. However, the results were
mixed. Lecithin and choline chloride, both substances containing the chemical structure of
choline, do not successfully improve memory performance [35, 36, 38–41]. However, cytidine
diphosphate choline (citicoline, CDP-choline) and choline alphoscerate (alpha-glyceryl-phos-
phoryl choline, alpha-GPC), both alternative compounds that contain choline, seem to be
promising substances in the treatment of progressively declining memory functioning in
human patients with dementia [42–45]. The discrepancy between the effects of these different
substances may relate to the complexity of the digestive system. Nonetheless, it remains unclear
why and which choline-containing substances improve memory. Here we extend this field of
research by testing the effects on memory functioning of another substance called choline
bitartrate.
Many of the studies discussed above manipulated choline availability in the diet. However,
the more acute effects of choline intake on memory performance have thus far not been investi-
gated in humans. Recent evidence suggest that choline has acute effects on the motor system,
which, as memory does, depends on cholinergic brain networks [46]. In the current study we
therefore investigated whether choline can affect performance on a variety of memory tasks an
hour after supplementation.
Most aforementioned studies used cholinergic substances to improve memory performance
in elderly patients with memory impairments. A recent study has further examined the effect
of choline on visual and auditory memory performance in healthy human adults, either by
itself or in combination with caffeine [47]. Although choline on its own did not lead to signifi-
cant improvements in memory performance they did find that a combination of 2g of choline
bitartrate and 25mg of caffeine significantly improved performance on both the visual and
auditory memory task compared to a placebo group. In a different experiment a combination
of 100mg of caffeine and 2g of choline also significantly improved performance on a backwards
digit span test compared to either caffeine or choline on its own [48]. This suggests that choline
bitartrate does have the ability to improve memory functioning in healthy human adults,
although the exact mechanism remains unclear. To examine whether high age and memory
improvements matter for choline to have effect, and to examine a larger target group than just
patients, we additionally investigated the effects of choline in a population of young, healthy,
human adults. In sum, the current study had two a priori goals: to investigate whether choline
bitartrate, a salt version of choline, could improve memory performance in healthy individuals
and to test what types of memory functions are improved by the ingestion of choline.
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Experiment 1 –Visuospatial Working Memory
Materials and Methods
The first experiment was designed to test the effects of choline bitartrate versus placebo intake
on visuospatial memory performance. We used a double-blind, placebo-controlled, random-
ized cross-over design with a counterbalanced order of conditions.
Participants. Thirty human individuals were recruited through the use of fliers and an
online advertisement placed on a university website for ongoing studies. Two participants
dropped out after session one. We eventually gathered data from 23 females and 5 males (age
M = 19.50, SD = 2.05, range = 18–28; body mass index: M = 22.67, SD = 2.72, range = 17.6–
29.8). All participants were right-handed students, received study credit or money for partici-
pation, gave informed written consent on paper before the experiment, and were debriefed
after the experiment. Participants were required to be between 18 and 35 years old, to have nor-
mal or corrected-to-normal vision, no cardiac, hepatic, renal, neurological or psychiatric disor-
ders, personal or family history of depression, migraine and no medication or drug use. All
female participants were tested only on days that they were using hormonal contraception.
Women who did not use hormonal contraceptives were therefore excluded from participation.
In this way hormonal confounds were limited, allowing for proper comparison across subjects
(for details, see [49]). In line with previous studies on the acute effects of choline on behavior
[46, 49–51] and to control for choline uptake unaffected by other supplements, participants
were restricted from drinking alcohol the day preceding the study and participants were not
allowed to have breakfast, coffee, or cigarettes before the experiment (overnight fasting, only
water and caffeine-free fruit tea without sugar allowed). Participants were naïve to the purpose
of the experiment and told that we investigated the effects of vitamin C on cognition. To pre-
vent that the students’ knowledge about food supplements would confound the results, the
experiment was deceptive: participants were led to believe that they drank orange juice
enriched with vitamin C. The experiments conformed to the ethical principles of the Declara-
tion of Helsinki and were approved by the local ethical committee “Commissie Ethiek Psycho-
logie” (Approval number: 5430110878 and 9406292569; For ethics guidelines concerning food
supplements, see http://media.leidenuniv.nl/legacy/richtlijnen-toediening-
voedingssupplementen.pdf; Leiden University, Institute for Psychological Research). There
were no minors (participants younger than 18 years old) involved in the here described
experiments.
Apparatus & materials. Depending on the session, participants were given 400ml of
orange juice including 2g of dissolved choline bitartrate or 2g of microcrystalline cellulose.
Choline bitartrate contains 41.1% choline by molecular weight (104 g/mol choline in 253 g/
mol choline bitartrate; Chemical info from Pubchem, an open chemistry database), resulting in
the administration of approximately 800mg of choline. Previous studies that have shown
effects of choline on memory performance in dementia patients [42, 43] required their subjects
to take 1200mg of choline alphoscerate a day (257g/mol), thus containing 485mg of choline a
day. We therefore assumed a one-time dose of 800mg well exceeding these dosages would suf-
fice to produce an acute effect on memory functioning in healthy young adults. The given
amounts were still well below the established 3.5g recommended upper level of daily intake for
adults [52] for safety purposes and to control for the fact that people typically ingest smaller
amounts of choline throughout the day (adequate intake of choline is ~500mg; Dietary Refer-
ence Intakes, Institute of Medicine). The choline bitartrate consisted of a white powder of pure
choline bitartrate ordered from www.bulkpowders.co.uk. Similarly, the microcrystalline cellu-
lose placebo also consisted of a white powder with a similar fine-grained structure as the cho-
line bitartrate. The choline bitartrate and microcrystalline cellulose were dissolved into the
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orange juice out of sight of the participant and it was not possible to distinguish the choline
bitartrate and placebo containing orange juice by either sight, smell, texture, or taste.
Stimuli were generated on an Asus Vivobook laptop computer with Windows 8 operating
system (Microsoft), using MatLab (Mathworks) and the Psychophysics toolbox extension [53].
The presentation monitor displayed 1366 by 768 pixels at a 60-Hz refresh rate. Screen size was
26cm in width and 17cm in height, and the participant’s viewing distance to the screen was
approximately half a meter. We measured heart rate (HR) and systolic and diastolic blood pres-
sure (SBP and DPB) at the non-dominant arm with an OSZ3 automatic digital electronic wrist
blood pressure monitor (Welch Allyn). Mood and arousal were measured using a pen and
paper on a 9 by 9 pleasure/valence x arousal grid [49, 54].
Stimuli and procedure. First the participant’s HR, SBP, DBP, and subjective mood. These
assessments were repeated an hour later right before the memory experiment and again
approximately 30 minutes later after the last task was completed. After the first assessment,
participants ingested 400ml of orange juice containing either dissolved choline bitartrate or
placebo. Fourteen participants took choline bitartrate in session 1 and placebo in session 2,
while the order was reversed for the remaining 14 participants (random group assignment).
The sessions were conducted on 2 separate days with approximately a week between sessions.
Choline bitartrate and placebo doses were prepared in sealed tubes by author MN and handed
over to the naïve experimenters. None of the participants was able to detect any difference in
the way the orange juice tasted between sessions.
The behavioral experiments were carefully timed to ensure that choline was taken up into
the participant’s system. In rats choline levels peak approximately 30 minutes after ingestion
[55, 56], and acetylcholine levels significantly raises after approximately 40 minutes [56] and
remains high for at least 90 minutes in rats [18]. In humans choline bitartrate increases choline
blood plasma levels within 1 hour after ingestion [57, 58] and with brain concentrations peak-
ing around 2 hours until at least up to 3 hours after ingestion [59, 60]. Choline’s effects on the
cholinergic peripheral system peaks between 1 and 2 hours after ingestion [46]. For these rea-
sons participants had to wait a full hour before conducting the behavioral tasks in each session
to ensure that choline was taken up into the system. The duration between supplement inges-
tion and the memory tasks was set to 60 minutes, not varying more than a couple minutes
across participants. Approximately half an hour after ingestion, participants were offered an
apple or orange to prevent hunger (both of which are known to contain no choline). Sessions
took approximately 1 hour and 30 minutes each to complete. Participants also performed a
visuospatial motor task which was unrelated to the memory task. Results of this task are pub-
lished in a different article [46].
The visuospatial memory task consisted of an adapted version of the popular children’s
game “Memory” that is known to depend on cholinergic functioning in healthy human adults
[61]. Participants played three blocks per session and the same pictures were presented in each
block to facilitate learning. Each block consisted of 5 distinct trials (i.e., 5 distinct sets of 9 dif-
ferent pictures) in which participants had to memorize the location of 9 target pictures (150 by
225 pixels). The targets were simultaneously shown for 10 seconds in a 3-by-3 grid on a grey
background (see Fig 1). To prevent that the task would be too easy and that participants would
memorize simple features instead of entire pictures, the pictures were selected from a set of nat-
ural images [62] exclusively consisting of cluttered scenes of trees and plants and without indi-
vidual objects and animals. Pictures were masked after presentation with a checkerboard
pattern for 4 seconds. This was followed by a cue of the target picture that was shown below
the grid. Participants had to retrieve the location of the target image from memory and click on
its previous location with a computer mouse cursor. The image at the selected location then
became visible for 2 seconds and the cue turned green or red depending on whether the
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participant had correctly or incorrectly indicated the location of the target, respectively. The
next target was automatically shown following the feedback display and each of the 9 picture
locations was consecutively tested within a trial. A total of 45 (5 x 9) pictures were tested within
a block and each block lasted approximately 5 minutes. Participants were debriefed about the
purpose of the experiment after the second session.
Statistical analysis. To test the effects of choline on working memory performance, we
conducted a paired student samples t-test on the number of correctly memorized picture loca-
tions between the choline bitartrate and placebo sessions. HR, SBP, DBP, mood, and arousal
were additionally tested for differences across sessions with the same analysis type. Bayes fac-
tors (BF) were calculated for the model “performance is larger after choline than placebo sup-
plementation” in the statistics program JASP [63].
Results & Discussion
Our first aim was to examine whether choline bitartrate improved visuospatial memory perfor-
mance an hour after ingestion. A t-test showed no significant difference between the choline
supplementation and placebo session on the number of correctly memorized picture locations
(Fig 2; t(27) = 0.28, p = 0.780; Choline: M = 66%, SD = 13%; Placebo: M = 66%, SD = 13%). As
the effect of choline may have depended on the participants’ Body Mass Indices (BMI), we
additionally calculated the correlation between performance differences between choline and
placebo and BMI. However, BMI did not correlate with the effect of choline versus placebo on
performance (r(26) = 0.03, p = 0.899). Furthermore, we found no effects of choline on HR,
Fig 1. Timeline, procedure, and stimuli of the visuospatial workingmemory task of experiment 1. Participants received a 2 gram dose of either choline
bitartrate or placebo in 2 separate sessions (cross-over design). A half hour after ingestion participants were allowed to eat some fruit and another half hour
later they performed a visuospatial memory task (a). Mood & arousal, heart rate, and blood pressure (MA,HR,BP) were assessed 3 times during each
session. The memory task was divided into 3 test blocks per session. In each block, participants completed 5 trials in which they had to memorize and
consecutively indicate each of the location of the 9 target pictures. Pictures were shown for 10 seconds during which participants were supposed to
memorize the locations of each picture (b). Pictures were then masked for 4 seconds and participants could subsequently indicate the location of the targets
(random presentation order) with a computer mouse. Feedback was given by changing the target in a green (correct location) or red (incorrect location)
patch. Pictures were shown in color but are here displayed in grayscale. The background color was grey during the experiment but is here displayed in white
for aesthetical reasons.
doi:10.1371/journal.pone.0157714.g001
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SBP, DBP, mood, and arousal (p’s> 0.05; see S1 Table). Results obtained from the Bayesian
analysis strongly favor the null-hypothesis that performance after choline supplementation is
not better than after placebo supplementation (Choline> Placebo BF10: 0.164; BF01: 6.096). To
summarize the results, choline bitartrate ingestion does not help healthy human participants to
store and maintain locations of stimuli in working memory. In the following experiment we
Fig 2. Results of visuospatial workingmemory task of experiment 1. Average percentage correctly
memorized picture locations across participants (chance = ~11%) per supplementation condition
(C = choline, P = placebo; n.s. = no significant difference).
doi:10.1371/journal.pone.0157714.g002
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assessed whether declarative memories, probed through picture familiarity ratings, could be
enhanced by choline bitartrate.
Experiment 2 –Declarative Memory
In the second experiment we sought to assess choline’s effects on declarative memory instead
of spatial working memory. Here we tested whether choline bitartrate intake improved recog-
nition of pictures that had either already been shown in a preceding encoding phase (old sti-
muli) or had not been shown to the participants before (new stimuli). The study design,
procedure, and apparatus were identical to experiment 1 except that the spatial memory task
was replaced by the declarative memory task and we did not assess the participants’ subjective
mood and arousal.
Materials and Methods
Participants. Twenty-eight participants, naïve about the purpose of the experiment were
tested in experiment two. The first participant was not able to complete the experiments due to
technical problems and another participant did not show up for the second session. We ended
up with data from 21 females and 5 males (age M = 21.18, SD = 3.49; range = 18–34; body
mass index: M = 22.11, SD = 2.17, range = 19.0–26.8). Participants satisfied the same criteria as
in experiment 1 but had not already taken part in experiment 1.
Stimuli and procedure. Sixty minutes post ingestion, participants performed a declarative
memory task which lasted approximately 30 minutes. The memory task was similar to the one
described in Naber and colleagues [64]. First, participants had to memorize 50 target pictures
(480 by 720 pixels) from the same database as used in experiment 1 (see encoding phase in Fig
3A). Each picture was shown for 1 second and preceded by a fixation dot for 4 seconds. The
Fig 3. Procedure and stimuli of declarative memory task of experiment 2. Participants first memorized
50 pictures in an encoding phase (a). Next, the same pictures were presented intermixed with 50 new
pictures (b). Participants indicated with 2 arrow buttons on a keyboard whether a presented picture was new
(i.e., not presented during memorization) or old (i.e., previously presented).
doi:10.1371/journal.pone.0157714.g003
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fixation dot was superimposed on the picture and participants were instructed to keep their
gaze strictly on the dot. The encoding phase lasted approximately 4 minutes. A minute later
following the encoding phase, the participants were tested on whether they had successfully
encoded the images into declarative memory (the retrieval phase). The test images were shown
intermixed with a new set of 50 pictures that were not previously shown in the encoding phase
(Fig 3B). During the retrieval phase, participants viewed a fixation dot for 1 second, followed
by the presentation of an old picture (i.e., previously shown) or a new picture for 4 seconds.
The picture then disappeared and the participant was presented with the written instructions
to press either the left or right arrow keyboard button to indicate whether the picture was new
or old, respectively. The fixation point and subsequent picture were automatically shown after
the response. There was no immediate feedback with regard to the accuracy of the participants’
response. The retrieval phase lasted approximately 10 minutes. Participants practiced the
encoding and retrieval task for about 3 minutes with a different and easier set of 10 target
images before the experiment.
Statistical analysis. Declarative memory performance was quantified by calculating the
percentage of hit trials (old image recognized as familiar) and correct rejection trials (novel
image recognized as unfamiliar). The same statistical tests as in experiment 1 were conducted.
Results & Discussion
We tested whether choline bitartrate improved declarative retrieval performance as compared
to placebo and we found no significant effect (Fig 4; t(25) = 0.91, p = 0.372; Choline> Placebo
BF10: 0.485; BF01: 2.063; Choline: M = 74%, SD = 9%; Placebo: M = 72%, SD = 11%). Body
Mass Index did not correlate with the effect of choline bitartrate versus placebo on perfor-
mance (r(26) = 0.14, p = 0.487). We found no effects of choline bitartrate on HR, SBP, and
DBP (p’s> 0.05; see S2 Table). To conclude, the results showed that the retrieval of partici-
pant’s declarative memories were not improved by choline bitartrate supplementation.
Experiment 3 –Replication and Verbal Working Memory
As the results from experiment 1 and 2 contrasted our expectations, we wondered whether the
null-results were a consequence of low statistical power or low choline concentrations.
Although the previously reported acute effects of choline bitartrate on visuomotor performance
were highly significant and strong [46], its effects on memory could be more subtle. Hence, we
designed a third experiment to replicate the results of experiment 1 and 2 but with a larger
sample size, a larger stimulus set, and a higher dose of choline bitartrate supplementation. We
also extended the set of tasks to assess choline’s effects on verbal working memory. Thus, the
study design, procedure, and apparatus were identical to experiment 1 except that experiment
3 included an extended visuospatial working memory task, an extended declarative memory
task, and an additional verbal working memory task.
Materials and Methods
Participants. Forty participants were tested in experiment 3. Three participants did not
complete the experiment for unknown reasons. We collected data from 30 females and 7 males
(age M = 21.53, SD = 2.74; range = 18–29; body mass index: M = 22.05, SD = 2.80,
range = 17.9–29.8). None of the participants had previously taken part in experiment 1 and 2.
Apparatus & materials. Depending on the session, participants were given 400ml orange
juice including either 2.5g dissolved choline bitartrate or 2.5g dissolved microcrystalline cellu-
lose. The choline bitartrate contained approximately 1g of effective choline. As the task
included the presentation of auditory stimuli, participants wore head phones.
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Stimuli and procedure. The visuospatial working memory and declarative memory pic-
ture task were identical to the tasks used in experiment 1 and 2, except for the doubled amount
of pictures. The verbal working memory task was a variant of the Buschke-task [65]. In the
original Buschke task, the researcher reads out 24 names of animal species which are then to be
recalled by the participant. Next, the researcher reads out those names that the participant was
Fig 4. Results of declarative memory task of experiment 2. Average percentage of correctly classified
pictures (chance = 50%) as old or new stimuli in the test phase across participants per choline and placebo
condition.
doi:10.1371/journal.pone.0157714.g004
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unable to recall and the participant is again asked to recall all of the 24 species names. This pro-
cess is reiterated until the entire list of names is recalled correctly or until a fixed number of
trial iterations has been performed. In the current version of the Buschke-task, the animal spe-
cies names were read out by a female voice with a 2 second interval in which each auditory
stimulus lasted approximately 1 second (Fig 5). Participants recalled the words by typing in
their responses on the computer one-by-one. The maximum number of trial iterations was set
to 5 (including the first trial). Because spelling could potentially pose a problem for some par-
ticipants, alternatives such as “Cheeta” instead of “Cheetah” were also counted as correct
recalls. Spelling errors were gathered during several pilot sessions.
Statistical analysis. Verbal working memory performance was quantified as the combined
total of forgotten items across all trials.
Results & Discussion
Neither visuospatial working memory (t(36) = 0.49, p = 0.630; Choline> Placebo BF10: 0.268;
BF01: 3.728; Choline: M = 70%, SD = 18%; Placebo: M = 72%, SD = 16%),), nor declarative
retrieval (t(36) = 0.70, p = 0.489; Choline> Placebo BF10: 0.111; BF01: 8.963; Choline:
M = 71%, SD = 15%; Placebo: M = 72%, SD = 11%), nor verbal working memory performance
(t(36) = 0.02, p = 0.987; Choline> Placebo BF10: 0.179; BF01: 5.585; Choline: M = 35, SD = 20;
Placebo: M = 35, SD = 19) were improved by choline bitartrate supplementation (Fig 6). BMI
did not correlate with the effect of choline versus placebo for visuospatial working memory
performance (r(35) = 0.10, p = 0.549), declarative retrieval performance (r(35) = 0.14,
p = 0.487), and verbal working memory performance (r(35) = 0.02, p = 0.890). We found no
effects of choline bitartrate supplementation on HR, SBP, DBP, mood, and arousal (p’s> 0.05;
see S3 Table). To conclude, the results showed that memory functions, as measured with a vari-
ety of tasks and tested on a large sample of participants than in experiment 1 and 2, were not
improved by choline bitartrate supplementation.
Fig 5. Procedure and stimuli of verbal workingmemory task of experiment 3. A total of 24 verbal animal species (a) were read out in 2 second intervals
(b). Next, the participant had to recall and type in all the names they remembered. Unrecalled words (misses) were read out again until the participant was
able to recall all words or until they had gone through 4 trial iterations.
doi:10.1371/journal.pone.0157714.g005
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General Discussion
In this study we have explored the effects of the dietary supplement choline bitartrate on mem-
ory functions in healthy human adults. Because choline is a precursor of the neurotransmitter
acetylcholine, we expected positive effects on memory. However, no evidence was found of a
beneficial effect of choline bitartrate supplementation on performance on a visuospatial work-
ing memory (experiment 1, 3), declarative long-term memory (experiment 2, 3), and verbal
working memory task (experiment 3). These results suggest that choline bitartrate does not
improve remembrance of spatial locations, declarative items, and verbal words.
Although these results are in contrast to expectations, there are a number of reasons that
may explain the current findings. However, we first rule out a couple factors that could not
underlie the null-results. The consistency of lacking differences between placebo and choline
across all experiments deems it unlikely that statistical power was too low. Another possibility
is that the effective dose of 1 gram choline may simply not be enough to have an effect. This,
again, is not likely as similar amounts are known to affect behavior in humans [46]. The possi-
bility that choline bitartrate was not synthesized to acetylcholine and could therefore not inter-
vene with cholinergic functions is also unlikely. Choline is known to improve behavioral
functions in healthy, young adults that rely on the cholinergic peripheral nervous system [46].
A perhaps more likely explanation is that the substance choline bitartrate may not affect cho-
linergic cell receptors in the central nervous system. Some chemicals may not be able to cross
the blood-brain barrier but still affect the peripheral nerves. The blood-brain barrier actually
keeps the central and peripheral neurotransmitter pools separate [66]. Alternatively, choline
may not be synthesized into acetylcholine at the brain regions important for memory. This
Fig 6. Results of memory tasks of experiment 3. Average percentage of correctly memorized picture locations in the
visuospatial working memory task (a), percentage of correctly classified pictures as old or new stimuli in the declarative
retrieval task (b), and number of forgotten items in the verbal working memory task (c) per choline and placebo
condition.
doi:10.1371/journal.pone.0157714.g006
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limitation would then have to be specific to choline bitartrate as the supplementation of other
choline-containing substances result in rapid increases in acetylcholine levels a variety of brain
regions in humans [57, 58, 60, 67, 68] and rats [22]. In line with this notion are results from a
study showing that a single dose of 2g of choline bitartrate also did not produce any effects on
either a visual or auditory memory task [47]. However, when combined with 25mg of caffeine
performance was significantly improved on both tasks compared to a placebo group. The
authors suggest that administration of choline bitartrate alone might lead to an oversaturation
in choline availability unless the synthesis of acetylcholine is stimulated through increases in
neuronal firing. Similarly, a combination of 100mg of caffeine and 2g of choline has been
shown to significantly improve performance on a backwards digit span test compared to either
caffeine or choline on its own [48]. Therefore the effectiveness of choline bitartrate on its own
might be limited unless for instance combined with a substance such as caffeine which is
thought to disinhibit neuronal firing through the release of adenosine. Another possible expla-
nation is that we might have been unable to find an effect of choline bitartrate on memory per-
formance due to individual differences in participants’ (baseline) neurochemical make-up. It is
not uncommon for the relationship between the availability of a neurotransmitter and task per-
formance to follow an inverted U-curve. Thus, additional acetylcholine synthesis might have
both improved and impaired memory performance depending on a participant’s baseline posi-
tion on the inverted U-curve. Lastly it might be possible that choline bitartrate has to be supple-
mented for a longer period of time before the memory system can benefit from its increased
availability.
The interpretations outlined above are speculative and further scientific explorations are
necessary before conclusions can be drawn on this issue. Unfortunately, it is not yet possible to
directly measure choline-to-acetylcholine synthesis in the human brain and assess choline’s
impact on cholinergic neural network activity.
The present study is the first to assess the acute effects of choline bitartrate supplementation
on performance in a variety of memory tasks. Previous results on the effects of cholinergic sub-
stances on memory performance were mixed [35, 36, 38–45], possibly due to differences in
populations and the type of cholinergic precursor. Future studies should therefore take into
account the type of cholinergic substance used in the experiment. Another limitation of this
study is the relatively large sample of female participants. It is first necessary to examine the
effects of choline on a larger sample of males before the data can be generalized.
To this end, it would be interesting to study potential interactions across food supplements.
Antioxidant, flavonoid, glucose, and fatty acid ingestion improve memory functions [69–75]
and the administration of a cocktail including these supplements together with choline may be
an interesting design for future studies. Future research may also further explore the role of
choline in the peripheral nervous system as it is known to acutely affect pupil size after inges-
tion [46].
As a final remark, the data reported in this article question the impact of choline on memory
functions in humans but also request for additional investigations to shed light on the actual
mechanism behind choline supplementation and previously reported memory improvements.
Nonetheless, we do not exclude the possibility that choline bitartrate could be an enhancer of
other, yet untested cognitive skills. Nevertheless, while recent studies show that choline supple-
mentation may help the elderly to recover from memory impairments [42–45], our experi-
ments suggest that there are no beneficial effects of choline bitartrate administration on
memory functioning in healthy, young individuals.
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